Open Pilot Trial of a Mind-Body Intervention for Patients With Chronic Hip Pain
Launched by MASSACHUSETTS GENERAL HOSPITAL · Feb 6, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new mind-body treatment for people with chronic hip pain, which is pain that has lasted for three months or longer. The study aims to see if this treatment, called HIPS, is practical and well-received by patients. They are looking for adults aged 18 and older who experience significant hip pain and have certain challenges related to physical activity and mental health. For instance, eligible participants might struggle with things like feeling overwhelmed by their pain or not being physically active enough.
Participants in this trial can expect to receive the HIPS treatment and share their experiences through interviews. The researchers will use this information to improve the program and prepare for a larger trial in the future. It's important to note that people who have had hip surgery or have pain coming from their lower back will not be eligible for this study. If you're interested in learning more or seeing if you qualify, the study is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Presenting with chronic (lasting ≥3 months) hip joint-related pain (HRP)
- • 2. Age ≥18yr
- • a. If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence \[KL\] grade 0-1)
- • 3. Score ≥3 for current hip pain on the Pain Visual Analogue Scale (Pain VAS)
- 4. Exhibits poor psychosocial health by meeting ≥1 of the criteria listed below:
- • 1. Score ≥ 20 on the Pain Catastrophizing Scale (PCS)
- • 2. Score ≤ 40 on the Pain Self-Efficacy Questionnaire (PSEQ)
- • 3. Score ≥ 17 on the Tampa Scale for Kinesiophobia (TSK-11)
- 5. Exhibits sedentariness by meeting ≥1 of the criteria listed below:
- • 1. Physically active \< 150mins/week according to the International Physical Activity Questionnaire (IPAQ)
- • 2. Hip pain interferes with ability to be physically active
- • 3. Dissatisfaction with current physical activity level
- Exclusion Criteria:
- • 1. Previous surgery on the symptomatic (painful) hip
- • 2. Current pain referred from the lower back
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported